U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055516) titled 'Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus' on May 30.
Brief Summary: A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Study Start Date: May 08
Study Type: INTERVENTIONAL
Condition:
Obesity and Type 2 Diabetes
Intervention:
DRUG: NT-0796
Orally administered capsules
DRUG: Placebo
Orally administered capsules
Recruitment Status: RECRUITING
...